Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Summary of warrants outstanding (Details)

v3.21.1
Stockholders' Equity - Summary of warrants outstanding (Details) - $ / shares
6 Months Ended 12 Months Ended
Feb. 28, 2021
Aug. 31, 2020
Number of shares    
Number of shares outstanding, beginning balance 1,896,209  
Issued 2,500,000  
Number of shares outstanding, ending balance 4,396,209  
Number of shares Exercisable 4,396,209  
Weighted remaining life (years)    
Weighted remaining life (years), beginning   4 years 8 months 12 days
Weighted remaining life (years), issued 5 years  
Weighted remaining life (years), cancelled 0 years  
Weighted remaining life (years), exercised 0 years  
Weighted remaining life (years), ending 4 years 6 months  
Weighted Remaining Life (Years) Exercisable 4 years 6 months  
Weighted average exercise prices    
Weighted average exercise prices, beginning $ 7.91  
Weighted average exercise prices, issued 3.30  
Weighted average exercise prices, ending 5.51  
Weighted Average Exercise Prices Exercisable $ 5.51